Drawing for CUSABIO

USPTO serial 79334764

CUSABIO

Reviewed by CopyMark Law Group

Reg. 7203814Status 700Registered
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
FENNESSY, EDWARD JOHN
Law office
TMEG LAW OFFICE 101

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CUSABIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road Suite 100Henderson, NV 89014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Protein in raw material form for scientific and medical research; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical test paper; bacterial preparations, other than for medical and veterinary use; preparations of microorganisms in the nature of inoculants, namely, biological microorganisms used in fermentation of silage, other than for medical and veterinary use; preparations of microorganisms, namely, diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria and viruses, other than for medical and veterinary use; chemical reagents, other than for medical or veterinary purposesACTIVE—
005Antibiotics for human use; Vaccines for human use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; pharmaceutical preparations, namely, antibody drugs for the treatment of cancer, tumors, anti-rejection of organ transplantation; pharmaceutical preparations for the treatment of tumors, cancer and infectious diseases, namely, antibodies, antibody derivatives, antibody-drug conjugates for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal drinks; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; dietetic substances adapted for medical use, namely, dietetic preparations, protein dietary supplementsACTIVE—
010Medical apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; apparatus for artificial respiration; diagnostic apparatus for medical purpose, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; breath gas analyzers for medical diagnostics; medical diagnostic instruments for the analysis of body fluids; medical instruments for analysing and identifying bacteria; dental apparatus, electric; galvanic therapeutic appliances; beds specially made for medical purposes; feeding bottles; orthopedic articles, namely, orthopedic braces; suture materialsACTIVE—
042Technological research in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; biological research; bacteriological research; chemistry services, namely, consultation in the field of chemistry, research and development services in the field of immunocytochemistry, chemical and biomolecular analysis, research in the fields of chemistry and biochemistry, chemical research laboratory services, consultancy in the field of biochemistry, research and development services in the field of biochemistry; chemical research; scientific laboratory services; conducting technical project studies, namely, conducting scientific project feasibility studies; conducting technical project studies in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies in the field of custom design and development of chemical reagents and biochemical assays; research and development of new products for others; chemical analysis; cosmetic researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 26, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 9, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 9, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 26, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 26, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2022RFNTREFUSAL PROCESSED BY IB—
Dec 7, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 7, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 27, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Mar 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance